Literature DB >> 26172946

Raman microspectroscopy of exhaled breath condensate and urine in workers exposed to fine and nano TiO2 particles: a cross-sectional study.

Daniela Pelclova1, Hana Barosova, Jana Kukutschova, Vladimir Zdimal, Tomas Navratil, Zdenka Fenclova, Stepanka Vlckova, Jaroslav Schwarz, Nadezda Zikova, Petr Kacer, Martin Komarc, Jaroslav Belacek, Sergey Zakharov.   

Abstract

The health effects of engineered nanoparticles in humans are not well-understood; however experimental data support the theory of oxidative stress promoting fibrogenesis and carcinogenicity. The aim of this study was to detect TiO2 particles in exhaled breath condensate (EBC) and urine samples to ascertain their presence and potential persistence and excretion in urine.EBC and urine samples were collected from 20 workers exposed to TiO2 aerosol; among them, 16 had a higher risk level of exposure (production workers) and four had medium risk level (research workers); in addition to 20 controls. Titanium levels in EBC and urine were analysed using the inductively coupled plasma mass spectrometry (ICP-MS) method. A Raman microspectroscopic analysis was performed in EBC and urine to identify the phase composition of TiO2 particles observed. Aerosol exposure in the workplaces was measured using SMPS and APS spectrometers and P-TRAK and DustTRAK DRX monitors.The median concentration of TiO2 aerosol was 1.98 × 10(4) particles cm(-3), the interquartile range (IQR) was 1.50 × 10(4) - 3.01 × 10(4) particles cm(-3) and the median mass concentration was 0.65 mg m(-3) (IQR 0.46-.0.83 mg m(-3)); 70-82% of the particles were smaller than 100 nm in diameter. In any part of the plant, the median TiO2 air concentration did not exceed the national airborne exposure limit of 10 mg m(-3) for inert dust. Particles of rutile and/or anatase were found in the EBC of exposed workers in 8/20 (40%) of the pre-shift and 14/20 (70%) of the post-shift samples. In the urine of workers, TiO2 particles were detected in 2/20 post-shift urine samples only. The mean concentration of titanium in the EBC in production workers was 24.1 ± 1.8 µg/l. In the research workers the values were below the limit of quantitation; LOQ = 4.0 ± 0.2 µg/l), as well as in the controls. In the urine samples of all of the subjects, titanium was under the limit of detection (LOD = 1.2 µg/l). Raman microanalysis of EBC in the workers confirmed the presence of TiO2 anatase and/or rutile crystal phases in the pre-shift samples and their persistence from previous shifts in the workers.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26172946     DOI: 10.1088/1752-7155/9/3/036008

Source DB:  PubMed          Journal:  J Breath Res        ISSN: 1752-7155            Impact factor:   3.262


  10 in total

Review 1.  Biological monitoring of workers exposed to engineered nanomaterials.

Authors:  P Schulte; V Leso; M Niang; I Iavicoli
Journal:  Toxicol Lett       Date:  2018-06-18       Impact factor: 4.372

2.  Current state of knowledge on the health effects of engineered nanomaterials in workers: a systematic review of human studies and epidemiological investigations.

Authors:  Paul A Schulte; Veruscka Leso; Mamadou Niang; Ivo Iavicoli
Journal:  Scand J Work Environ Health       Date:  2019-01-17       Impact factor: 5.024

Review 3.  Evolution of clinical and environmental health applications of exhaled breath research: Review of methods and instrumentation for gas-phase, condensate, and aerosols.

Authors:  M Ariel Geer Wallace; Joachim D Pleil
Journal:  Anal Chim Acta       Date:  2018-02-09       Impact factor: 6.558

Review 4.  Transition and post-transition metals in exhaled breath condensate.

Authors:  Andrew J Ghio; Michael C Madden; Charles R Esther
Journal:  J Breath Res       Date:  2018-02-07       Impact factor: 3.262

5.  Enhanced antioxidant capacity prevents epitranscriptomic and cardiac alterations in adult offspring gestationally-exposed to ENM.

Authors:  Amina Kunovac; Quincy A Hathaway; Mark V Pinti; Andrya J Durr; Andrew D Taylor; William T Goldsmith; Krista L Garner; Timothy R Nurkiewicz; John M Hollander
Journal:  Nanotoxicology       Date:  2021-05-08       Impact factor: 5.913

6.  Identification of the phase composition of solid microparticles in the nasal mucosa of patients with chronic hypertrophic rhinitis using Raman microspectroscopy.

Authors:  Kristina Čabanová; Oldřich Motyka; Hana Bielniková; Lenka Čábalová; Petr Handlos; Dominika Zabiegaj; Karol Zeleník; Jana Dvořáčková; Pavel Komínek; Silvie Heviánková; Miroslav Havlíček; Jana Kukutschová
Journal:  Sci Rep       Date:  2021-09-23       Impact factor: 4.379

7.  Towards a toxic-free environment: perspectives for chemical risk assessment approaches.

Authors:  Matteo Bonzini; Veruscka Leso; Ivo Iavicoli
Journal:  Med Lav       Date:  2022-02-22       Impact factor: 1.275

8.  A Biomonitoring Pilot Study in Workers from a Paints Production Plant Exposed to Pigment-Grade Titanium Dioxide (TiO2).

Authors:  Enrico Bergamaschi; Valeria Bellisario; Manuela Macrì; Martina Buglisi; Giacomo Garzaro; Giulia Squillacioti; Federica Ghelli; Roberto Bono; Ivana Fenoglio; Francesco Barbero; Chiara Riganti; Antonella Marrocco; Sara Bonetta; Elisabetta Carraro
Journal:  Toxics       Date:  2022-03-31

9.  Deep Airway Inflammation and Respiratory Disorders in Nanocomposite Workers.

Authors:  Daniela Pelclova; Vladimir Zdimal; Martin Komarc; Stepanka Vlckova; Zdenka Fenclova; Jakub Ondracek; Jaroslav Schwarz; Martin Kostejn; Petr Kacer; Stepanka Dvorackova; Alexey Popov; Pavlina Klusackova; Sergey Zakharov; Dhimiter Bello
Journal:  Nanomaterials (Basel)       Date:  2018-09-16       Impact factor: 5.076

10.  Markers of Oxidative Stress in the Exhaled Breath Condensate of Workers Handling Nanocomposites.

Authors:  Daniela Pelclova; Vladimir Zdimal; Jaroslav Schwarz; Stepanka Dvorackova; Martin Komarc; Jakub Ondracek; Martin Kostejn; Petr Kacer; Stepanka Vlckova; Zdenka Fenclova; Alexey Popov; Lucie Lischkova; Sergey Zakharov; Dhimiter Bello
Journal:  Nanomaterials (Basel)       Date:  2018-08-10       Impact factor: 5.076

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.